Pediatric Oncology Drugs

Oncology drugs are targeted to specific organs or locations in the body. Approval of new cancer drugs for pediatric patients generally occurs after their development and approval for treating adult cancers. As most drug development occurs in the industry setting, the relatively small market of pediatric oncology does not provide the financial incentives for companies to actively pursue pediatric oncology solutions. Larotrectinib is the first cancer drug to receive FDA breakthrough therapy designation for patients with a specific fusion of two genes in the cancer cell, no matter what cancer type. The research appears in The Lancet Oncology. To understand challenges in childhood cancer drug development better, how all of biomedical research is supported at the national and international levels needs to be considered. In the USA, approximately 60% of funding for biomedical research stems from the private biopharmaceutical sector.

    Related Conference of Pediatric Oncology Drugs

    February 24-25, 2025

    24th Annual World Congress on Neonatology

    Toronto, Canada
    February 24-25, 2025

    34th World Congress on Clinical Pediatrics

    Toronto, Canada
    March 10-11, 2025

    23rd  World Congress on Clinical Pediatrics

    Toronto, Canada
    March 24-25, 2025

    2nd World Pediatric Conference

    London, UK
    March 24-25, 2025

    39th Global Summit on Pediatrics

    London, UK
    April 16-17, 2025

    2nd World Congress on Pediatrics and Nutrition

    Tokyo, Japan
    April 16-17, 2025

    4th International Congress on Pediatrics

    Tokyo, Japan
    April 23-24, 2025

    4th World Congress on Pediatric Cardiology

    Amsterdam, Netherlands
    May 12-13, 2025

    5th Global Summit on Pediatric Nursing

    Toronto, Canada
    May 14-15, 2025

    9th International Conference on Pediatric Nutrition

    Barcelona, Spain
    May 14-15, 2025

    4th International Conference on Neonatology

    Toronto, Canada
    May 15-16, 2025

    37th European Pediatrics Congress

    Paris, France
    May 26-27, 2025

    38th World Pediatrics Conference

    Rome, Italy
    June 04-05, 2025

    25th World Congress on Pediatric Neurology and Neuropathology

    Amsterdam, Netherlands
    June 04-05, 2025

    26th World Congress on Pediatric Oncology and Cancer Care

    Edinburgh, Scotland
    July 14-15, 2025

    26th Annual World Congress on Pediatrics

    Zurich, Switzerland
    July 21-22, 2025

    7th Annual Congress on Pediatric Cardiology

    Toronto, Canada
    August 11-12, 2025

    33rd International Conference on Pediatrics Health

    Toronto, Canada
    September 11-12, 2025

    20th European Congress on Clinical Pediatrics and Child Care

    Budapest, Hungary
    September 18-19, 2025

    41st International Conference on Pediatric and Nutritional Research

    Amsterdam, Netherlands
    October 20-21, 2025

    36th European Pediatrics Conference

    Barcelona, Spain

    Pediatric Oncology Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in